Jonathan E. Dowell
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Occupational and environmental lung diseases
- Oncology top 2%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Lung Cancer Treatments and Mutations 26
- Lung Cancer Diagnosis and Treatment 12
- Occupational and environmental lung diseases 7
- Pleural and Pulmonary Diseases 6
- Oncology 33
- Lung Cancer Research Studies 9
- Cancer Immunotherapy and Biomarkers 9
- HER2/EGFR in Cancer Research 6
- Colorectal Cancer Treatments and Studies 6
- Co-authors
- David E. Gerber (22 shared papers)John Dorrance Minna (8 shared papers)Puneeth Iyengar (8 shared papers)Hak Choy (4 shared papers)Zabi Wardak (4 shared papers)Robert D Timmerman (5 shared papers)Chul Woo Ahn (5 shared papers)Randall S. Hughes (4 shared papers)
- Journals
- Journal of the National Comprehensive Cancer Network (9 papers)Journal of Clinical Oncology (6 papers)International Journal of Radiation Oncology*Biology*Physics (5 papers)The American Journal of the Medical Sciences (4 papers)Lung Cancer (4 papers)
- Partner nations
- United StatesIndiaCanada
In The Last Decade
Jonathan E. Dowell
97 papers receiving 5.6k citations
Jonathan E. Dowell's Hit Papers
Peers
Comparison fields: 5 of 114
- Pulmonary and Respiratory Medicine 2.6k
- Oncology 1.8k
- Cancer Research 554
- Radiation 188
- Toxicology 68
Countries citing papers authored by Jonathan E. Dowell
This map shows the geographic impact of Jonathan E. Dowell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan E. Dowell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan E. Dowell more than expected).
Fields of papers citing papers by Jonathan E. Dowell
This network shows the impact of papers produced by Jonathan E. Dowell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan E. Dowell. The network helps show where Jonathan E. Dowell may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan E. Dowell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2022 | 1007 |
| 2 | Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer Hit paper breakdown → | 2017 | 816 |
| 3 | NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021 Hit paper breakdown → | 2021 | 756 |
| 4 | Non–Small Cell Lung Cancer, Version 4.2024 Hit paper breakdown → | 2024 | 423 |
| 5 | NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023 Hit paper breakdown → | 2023 | 339 |
| 6 | 2014 | 247 | |
| 7 | 2005 | 192 | |
| 8 | 2022 | 134 | |
| 9 | Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer Hit paper breakdown → | 2024 | 105 |
| 10 | 2012 | 95 | |
| 11 | 2018 | 82 | |
| 12 | 2018 | 79 | |
| 13 | 2006 | 76 | |
| 14 | 2012 | 74 | |
| 15 | 2021 | 71 | |
| 16 | 2015 | 60 | |
| 17 | 2013 | 51 | |
| 18 | 2001 | 47 | |
| 19 | 2010 | 47 | |
| 20 | 2015 | 47 |
About Jonathan E. Dowell
Jonathan E. Dowell is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Hematology, Molecular Biology and Cancer Research, having authored 100 papers that have together received 5.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (26 papers), Lung Cancer Diagnosis and Treatment (12 papers), Lung Cancer Research Studies (9 papers), Cancer Immunotherapy and Biomarkers (9 papers), Occupational and environmental lung diseases (7 papers), HER2/EGFR in Cancer Research (6 papers), Colorectal Cancer Treatments and Studies (6 papers) and Pleural and Pulmonary Diseases (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.6k citations), Oncology (1.8k citations), Cancer Research (554 citations), Radiation (188 citations) and Toxicology (68 citations). Jonathan E. Dowell has collaborated with scholars based in United States, India and Canada. Frequent co-authors include David E. Gerber, John Dorrance Minna, Puneeth Iyengar, Hak Choy, Zabi Wardak, Robert D Timmerman, Chul Woo Ahn, Randall S. Hughes, Peter N. Kirkpatrick and Kenneth D. Westover. Their work appears in journals such as Journal of the National Comprehensive Cancer Network, Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, The American Journal of the Medical Sciences and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.